Please assess the completion status of the following clinical trial:

Trial Title: Partial Oral Treatment of Endocarditis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Left-sided endocarditis based on the Duke criteria~* Infected with one of the following microorganisms:~  * Streptococci~ * Enterococcus faecalis~ * Staphylococcus aureus~ * Coagulase-negative staphylococci.~* ≥ 18 years~* At least 10 days of appropriate parenteral antibiotic treatment overall, and at least 1 week of appropriate parenteral treatment after valve surgery~* Afebrile (T \< 38.0) \> 2 days~* Decreasing infection parameters (CRP dropped to less than 25% of peak value or \< 20 mg/l, and white blood cell count \< 15 x 109/l) during antibiotic treatment~* No sign of abscess formation by echocardiography~* Transthoracic and transoesophageal echocardiography performed within 48 hours prior to randomization~Exclusion Criteria:~* Body mass index \> 40~* Concomitant infection requiring intravenous antibiotic therapy~* Inability to give informed consent to participation~* Suspicion of reduced absorption of oral treatment due to abdominal disorder~* Reduced compliance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Guideline treatment with parenteral antibiotics (Type: ACTIVE_COMPARATOR): Guideline treatment with parenteral antibiotics
- Oral treatment with antibiotics (Type: EXPERIMENTAL): Oral treatment with antibiotics based on resistens pattern

Based on this trial design, predict the completion outcome and termination type (if applicable).